174 related articles for article (PubMed ID: 29320775)
1. Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Cancer Aggravated by Steroid Therapy.
Kang MK; Park JG; Lee HJ
Med Princ Pract; 2018; 27(2):197-200. PubMed ID: 29320775
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic cholestatic jaundice may be a paraneoplastic manifestation of underlying malignancy: a case of prostate cancer.
Okano A; Ohana M; Kusumi F
Clin J Gastroenterol; 2014 Jun; 7(3):278-82. PubMed ID: 26183750
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic cholestasis associated with prostate carcinoma.
Koruk M; Büyükberber M; Savaş C; Kadayifçi A
Turk J Gastroenterol; 2004 Mar; 15(1):53-5. PubMed ID: 15264123
[TBL] [Abstract][Full Text] [Related]
4. Non-obstructive jaundice as a paraneoplastic syndrome of prostate carcinoma.
Martín Enguix D; Alarcón Blanco PA; Lacorzana J
Med Clin (Barc); 2022 Mar; 158(6):294-295. PubMed ID: 34362577
[No Abstract] [Full Text] [Related]
5. Stauffer's syndrome with jaundice, a paraneoplastic manifestation of renal cell carcinoma: a case report.
Tomadoni A; García C; Márquez M; Ayala JC; Prado F
Arch Esp Urol; 2010 Mar; 63(2):154-6. PubMed ID: 20378939
[TBL] [Abstract][Full Text] [Related]
6. Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma.
Karakolios A; Kasapis C; Kallinikidis T; Kalpidis P; Grigoriadis N
Clin Gastroenterol Hepatol; 2003 Nov; 1(6):480-3. PubMed ID: 15017648
[TBL] [Abstract][Full Text] [Related]
7. Stauffer's syndrome variant associated with renal cell carcinoma.
Giannakos G; Papanicolaou X; Trafalis D; Michaelidis I; Margaritis G; Christofilakis C
Int J Urol; 2005 Aug; 12(8):757-9. PubMed ID: 16174051
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic presentation of cholestatic jaundice in renal cell carcinoma.
Akbulut S; Baysal A; Topal F
Turk J Gastroenterol; 2014 Jun; 25(3):340-1. PubMed ID: 25141330
[No Abstract] [Full Text] [Related]
9. Paraneoplastic neurological and hematological syndromes associated with prostate cancer.
Gakiya M; Naka H; Saito S
Int J Urol; 2012 May; 19(5):471-4. PubMed ID: 22220977
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic jaundice and prostate cancer.
Vieira AC; Alvarenga MJ; Santos JC; Silva AM
BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28433972
[TBL] [Abstract][Full Text] [Related]
11. Metastatic prostate cancer presenting as paraneoplastic pemphigus: a favourable clinical response to combined androgen blockade and conventional immunosuppressive therapy.
Mignogna MD; Fortuna G; Leuci S; Adamo D; Ruoppo E
Br J Dermatol; 2009 Feb; 160(2):468-70. PubMed ID: 19120335
[No Abstract] [Full Text] [Related]
12. Distal phalangeal necrosis in the extremities as a paraneoplastic syndrome in prostate cancer: an extremely rare case.
Akin Y; Yucel S; Baykara M
Urol Int; 2014; 93(2):244-6. PubMed ID: 24281198
[TBL] [Abstract][Full Text] [Related]
13. Stauffer's syndrome variant with cholestatic jaundice: a case report.
Morla D; Alazemi S; Lichtstein D
J Gen Intern Med; 2006 Jul; 21(7):C11-3. PubMed ID: 16808761
[TBL] [Abstract][Full Text] [Related]
14. Non-obstructive jaundice as paraneoplastic syndrome of prostate carcinoma: Systematic review of published cases.
Santandreu-Morales I; Redondo-Cerezo E; Martín-Enguix D
Med Clin (Barc); 2023 Mar; 160(5):206-212. PubMed ID: 36526448
[TBL] [Abstract][Full Text] [Related]
15. Prostate Cancer Presenting with Pruritus and Cholestasis.
Kim YH; Park JM; Kang CD; Seo SO; Lee K; Song G
Korean J Gastroenterol; 2021 Jul; 78(1):59-64. PubMed ID: 34312359
[TBL] [Abstract][Full Text] [Related]
16. [Dermatomyositis as a paraneoplastic syndrome].
Wennekers MM; Appelman M; van der Weele WF
Ned Tijdschr Geneeskd; 2018; 161():D1916. PubMed ID: 29473536
[TBL] [Abstract][Full Text] [Related]
17. Cholestatic jaundice as a paraneoplastic manifestation of prostate cancer.
Kuramoto T; Senzaki H; Koike H; Yamagiwa K; Tamura S; Fujimoto T; Inagaki T
Case Rep Urol; 2013; 2013():303727. PubMed ID: 24191227
[TBL] [Abstract][Full Text] [Related]
18. Fulminant digital necrosis in a patient with prostate adenocarcinoma.
Paolini MV; Jankilevich G; Graziano C; Fernández Romero DS
Allergol Immunopathol (Madr); 2010; 38(1):48-50. PubMed ID: 19836875
[No Abstract] [Full Text] [Related]
19. Vanishing bile duct syndrome in non-Hodgkin lymphoma: a case report.
Foramiti S; Biondini E; Bigolin T; Pasca S; Rossi P
Minerva Med; 2011 Aug; 102(4):345-9. PubMed ID: 21959708
[TBL] [Abstract][Full Text] [Related]
20. Cerebellar manifestations of prostatic carcinoma.
McLoughlin J; Gingell JC; Harper G; Hinchliffe A
Postgrad Med J; 1992 Jul; 68(801):584-6. PubMed ID: 1437959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
